60.12
Precedente Chiudi:
$63.29
Aprire:
$63.64
Volume 24 ore:
43,433
Relative Volume:
0.63
Capitalizzazione di mercato:
$424.89M
Reddito:
-
Utile/perdita netta:
$-4.98M
Rapporto P/E:
-45.62
EPS:
-1.3177
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
+16.66%
1M Prestazione:
+23.24%
6M Prestazione:
+108.39%
1 anno Prestazione:
+5,463%
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Nome
Bright Minds Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta DRUG con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
DRUG
Bright Minds Biosciences Inc
|
60.32 | 448.64M | 0 | -4.98M | -3.85M | -1.3177 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.81 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-08 | Iniziato | BTIG Research | Buy |
2025-05-13 | Iniziato | TD Cowen | Buy |
2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
2025-01-23 | Iniziato | Piper Sandler | Overweight |
2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
2025-01-10 | Iniziato | H.C. Wainwright | Buy |
2024-11-26 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Will Bright Minds Biosciences Inc. outperform the marketJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
Exit strategy if you’re trapped in Bright Minds Biosciences Inc.2025 Short Interest & Fast Moving Trade Plans - newser.com
Visualizing Bright Minds Biosciences Inc. stock with heatmaps2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Has Bright Minds Biosciences Inc. found a price floorJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Insiders Who Sold CA$17m Of Bright Minds Biosciences Made The Right Call - simplywall.st
Published on: 2025-10-10 09:53:23 - newser.com
Risk vs reward if holding onto Bright Minds Biosciences Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
How to use Fibonacci retracement on Bright Minds Biosciences Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
What technical models suggest about Bright Minds Biosciences Inc.’s comebackQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Regression analysis insights on Bright Minds Biosciences Inc. performanceMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
Published on: 2025-10-09 04:28:20 - newser.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $81.00 Consensus Target Price from Analysts - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Stock Rating Lowered by Wall Street Zen - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Rating of "Buy" from Analysts - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Cut to Sell at Wall Street Zen - MarketBeat
Will Bright Minds Biosciences Inc. stock outperform growth indexesJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
BTIG Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $72 - 富途牛牛
Published on: 2025-09-30 11:54:24 - earlytimes.in
What analysts say about Bright Minds Biosciences Inc stockResistance Zone Identification & High Return Investment Plans - earlytimes.in
Is Bright Minds Biosciences Inc a good long term investmentMarket Liquidity Analysis & Explosive Capital Growth Plans - earlytimes.in
What drives Bright Minds Biosciences Inc stock priceAI-Driven Market Analysis & Low Risk Investment Growth - earlytimes.in
Bright Minds Biosciences Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Fast Profit Stock Ideas - Early Times
H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛
Goldman Sachs Group Inc. Takes Position in Bright Minds Biosciences Inc. $DRUG - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Hold at Wall Street Zen - MarketBeat
Relative strength of Bright Minds Biosciences Inc. in sector analysisProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com
Using data filters to optimize entry into Bright Minds Biosciences Inc.July 2025 Gainers & Precise Buy Zone Identification - newser.com
Bright Minds Biosciences (NASDAQ:DRUG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Chart based analysis of Bright Minds Biosciences Inc. trendsEarnings Trend Report & High Accuracy Trade Alerts - newser.com
Portfolio Update: How is Bright Minds Biosciences Inc managing supply chain issues2025 Winners & Losers & Free High Return Stock Watch Alerts - khodrobank.com
How to forecast Bright Minds Biosciences Inc. trends using time seriesOptions Play & Fast Gain Stock Trading Tips - newser.com
What data driven models say about Bright Minds Biosciences Inc.’s futureMarket Performance Report & Verified Short-Term Trading Plans - newser.com
HC Wainwright Reaffirms "Buy" Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat
Aug Sectors: What is HIPOs 5 year growth outlookEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com
S P Trends: What is Bright Minds Biosciences Inc. s revenue forecast2025 Biggest Moves & Precise Buy Zone Tips - خودرو بانک
Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade - Yahoo Finance
Bright Minds Biosciences Reports Q3 2025 Financial Results - MSN
Growth Report: Is Driven Brands Holdings Inc. undervalued by DCF analysisJuly 2025 Weekly Recap & High Conviction Trade Alerts - خودرو بانک
Bright Minds rebounds after $35M private placement - MSN
Will Bright Minds Biosciences Inc benefit from rate cutsJuly 2025 Final Week & Short-Term High Return Strategies - خودرو بانک
Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bright Minds Biosciences Inc Azioni (DRUG) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Cormorant Asset Management, LP | 10% Owner |
Oct 15 '24 |
Buy |
5.53 |
372,591 |
2,061,574 |
825,000 |
Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):